Clinical Trial Update: Advanced Immunological Approach in COPD Exacerbation [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating an advanced immunological approach for COPD exacerbations has completed. The sponsor is Lallemand Pharma AG.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Snippet

Sponsor: Lallemand Pharma AG | Conditions: Chronic Obstructive Pulmonary Disease (COPD) | Phase 4 | Status: COMPLETED